Optimal treatment intensity in children with Down syndrome and myeloid leukaemia: data from 56 children treated on NOPHO-AML protocols and a review of the literature-Reference-Cited by-同舟云学术

Optimal treatment intensity in children with Down syndrome and myeloid leukaemia: data from 56 children treated on NOPHO-AML protocols and a review of the literature

Published:2006-03-04 Issue:5 Volume:85 Page:275-280
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Abildgaard Lotte,Ellebæk Eva,Gustafsson Göran,Abrahamsson Jonas,Hovi Liisa,Jonmundsson Gudmundur,Zeller Bernward,Hasle Henrik

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-005-0045-5.pdf

Reference19 articles.

1. Gurbuxani S, Vyas P, Crispino JD (2004) Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome. Blood 103:399–406

2. Hasle H, Niemeyer CM, Chessells JM, Baumann I, Bennett JM, Kerndrup G, Head DR (2003) A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia 17:277–282

3. Gamis AS, Woods WG, Alonzo TA, Buxton A, Lange B, Barnard DR, Gold S, Smith FO (2003) Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the children's cancer group study 2891. J Clin Oncol 21:3415–3422

4. Ravindranath Y (2003) Down syndrome and acute myeloid leukemia: the paradox of increased risk for leukemia and heightened sensitivity to chemotherapy. J Clin Oncol 21:3385–3387

5. Creutzig U, Reinhardt D, Diekamp S, Dworzak M, Stary J, Zimmermann M (2005) AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity. Leukemia 19:1355–1360

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloid Proliferation Associated with Down Syndrome (ML-DS, TAM);Pediatric Oncology;2024

2. Health-related quality of life of a child with Trisomy 21 and Acute Myeloid Leukemia: Case report;RGO - Revista Gaúcha de Odontologia;2024

3. Survival outcomes of myeloid leukemia associated with Down syndrome and de novo acute myeloid leukemia in children: Experience from a single tertiary center in Thailand;Pediatric Hematology and Oncology;2023-11-27

4. Down syndrome and leukemia: An insight into the disease biology and current treatment options;Blood Reviews;2023-11

5. Survival outcomes of children with relapsed or refractory myeloid leukemia associated with Down syndrome;Blood Advances;2023-10-27